Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Vas Narasimhan wants Novartis to have a big focus on China. Here’s what that looks like
Endpoints
Thu, 01/30/20 - 10:49 am
Tags:
Novartis, China, Pharma CEOs, Vas Narasimhan
Novartis gives up on Advair generic, leaving Mylan as sole competitor
BioPharma Dive
Wed, 01/29/20 - 11:52 pm
Tags:
Novartis, generics, Advair, Mylan
Novartis Earnings Narrowly Top; Drug Giant Rises In Buy Zone
Investors Business Daily
Wed, 01/29/20 - 10:38 am
Tags:
Novartis, earnings
Novartis gene therapy for fatal childhood disease delivers strong sales during fourth quarter
Stat
Wed, 01/29/20 - 10:37 am
Tags:
Novartis, Zolgensma, SMA
Acceleron’s post-Reblozyl plan comes together
EP Vantage
Tue, 01/28/20 - 11:09 am
Tags:
Acceleron, sotatercept, PAH, JNJ, Bellerophon Therapeutics, United Therapeutics, Vivus, Arena, Novartis
Life after Novartis: Jimenez joins board of Bayer-backed cell therapy startup
Fierce Biotech
Tue, 01/28/20 - 11:03 am
Tags:
Joe Jimenez, Novartis, Bayer, Century Therapeutics, cell therapy
Trifecta of sickle cell disease therapies extend life expectancy, but are not cost-effective — ICER
Endpoints
Fri, 01/24/20 - 10:30 am
Tags:
ICER, sickle cell disease, Novartis, Adakveo, Global Blood Therapeutics, Oxbryta, Emmaus Life Sciences, Endari
5 biopharmas to watch as the decade's last earnings kick off
BioPharma Dive
Wed, 01/22/20 - 11:06 am
Tags:
earnings, Novartis, Biogen, Eli Lilly, Global Blood Therapeutics, Bluebird Bio
Ionis, Akcea boosted by a positive PhII for their Novartis castoff cardio drug — and they plan to push ahead into pivotals
Endpoints
Wed, 01/22/20 - 11:00 am
Tags:
Novartis, Akcea, Medco, AKCEA-APOCIII-LRx, antisense
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
Fri, 01/17/20 - 11:41 pm
Tags:
innovation, Regeneron, Verily, Illumina, Biogen, Bayer, Bluebird Bio, Novartis, GSK, Genentech, Amgen
Novartis' David Lennon on next steps for AveXis, selling Zolgensma's price to the public
BioPharma Dive
Wed, 01/15/20 - 11:36 pm
Tags:
Novartis, SMA, AveXis, Zolgensma, drug pricing
Novartis Starts 2020 a Step Ahead of Other Big Pharmas with the Most Newly Approved Drugs
Motley Fool
Wed, 01/15/20 - 11:01 pm
Tags:
Novartis, FDA, drug approvals
AbbVie and Boehringer Ingelheim's Skyrizi Beat Novartis' Cosentyx in Plaque Psoriasis
Motley Fool
Wed, 01/15/20 - 10:56 am
Tags:
AbbVie, Boehringer Ingelheim, Skyrizi, Novartis, Cosentyx, psoriasis
JPM: New Novartis pharma chief rethinks its drug-launch formula
Fierce Pharma
Wed, 01/15/20 - 10:49 am
Tags:
Novartis, Pharma CEOs, Vas Narasimhan, drug launches, JPMHC 2020
Roche aims to 'underwhelm' with risdiplam price as it enters SMA rivalry with Biogen, Novartis — report
Endpoints
Tue, 01/14/20 - 10:20 am
Tags:
SMA, Roche, risdiplam, Biogen, Novartis, drug pricing
JPM kickoff: Gilead's deal ideal, Novartis' image-polishing, Teva's shutdown tally and one CEO's word on another
Fierce Pharma
Mon, 01/13/20 - 11:55 pm
Tags:
JPMHC 2020, Teva Pharmaceuticals, Novartis, Gilead Sciences, M&A, Pharma CEOs
JPM: With new ethics plan, Novartis chief puts his money where his mouth is
Fierce Pharma
Mon, 01/13/20 - 11:45 pm
Tags:
Novartis, ethics, Pharma CEOs, Vas Narasimhan, JPMHC 2020
Aduro's staffers feel the sting, again, after Novartis walks away
Fierce Biotech
Fri, 01/10/20 - 10:35 am
Tags:
Aduro BioTech, layoffs, Novartis
A big finish confirms 2019 as a takeover year to remember
EP Vantage
Thu, 01/9/20 - 10:49 am
Tags:
M&A, AbbVie, Allergan, Astellas, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Sanofi
Novartis, Merck and Allergan raise drug prices to start 2020, joining Big Pharma peers
Fierce Pharma
Mon, 01/6/20 - 10:46 am
Tags:
drug pricing, Merck, Allergan, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.